AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Praxis Precision Medicines (PRAX) rose 8% in pre-market trading after announcing a $525m public share offering. Western Alliance Bancorporation (WAL) shares fell 11% due to concerns over credit risk in the US banking sector. Rigetti Computing (RGTI) was also trending, while Micron Technology (MU) and Smiths Group (SMG) saw increased interest.
Praxis Precision Medicines (PRAX) shares surged 8% in pre-market trading on September 12, 2025, following the announcement of a $525 million public share offering. The company's stock price reached a new high of $250.00, nearly doubling its price target set by Oppenheimer, which was initially $115.00. This significant increase is largely attributed to the positive Phase 3 clinical trial results for its essential tremor treatment, ulixacaltamide. The drug successfully met all endpoints in Study-1 and its primary endpoint in Study-2, demonstrating a competitive safety profile compared to propranolol, the current standard treatment for essential tremor, according to an .
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet